XML 123 R107.htm IDEA: XBRL DOCUMENT v3.6.0.2
Schedule II. Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Operating activities      
Net cash (used in) provided by operating activities $ 114,212 $ 92,859 $ 140,684
Investing activities      
Purchases of property and equipment (1,638) (953) (989)
Net cash (used in) provided by investing activities (50,478) (49,820) (141,252)
Financing activities      
Proceeds from stock option exercises 837 1,844 2,674
Tax benefit from share-based payments 995 2,203 2,841
Dividends to shareholders (76,111) (68,561) (37,068)
Net cash used in financing activities (74,279) (64,514) (31,553)
Change in cash and cash equivalents (10,545) (21,475) (32,121)
Cash and cash equivalents at beginning of year 69,481 90,956 123,077
Cash and cash equivalents at end of year 58,936 69,481 90,956
Parent Company [Member]      
Operating activities      
Net cash (used in) provided by operating activities 2,771 (1,727) 2,161
Investing activities      
Purchases of investments (11,940)   (1,462)
Proceeds from sales of investments   250 2,404
Purchases of property and equipment (924) (627) (691)
Dividends from subsidiary 67,000 50,000 25,000
Net cash (used in) provided by investing activities 54,136 49,623 25,251
Financing activities      
Proceeds from stock option exercises 837 1,844 2,674
Tax benefit from share-based payments 995 2,204 2,841
Dividends to shareholders (76,111) (68,561) (37,068)
Net cash used in financing activities (74,279) (64,513) (31,553)
Change in cash and cash equivalents (17,372) (16,617) (4,141)
Cash and cash equivalents at beginning of year 26,968 43,585 47,726
Cash and cash equivalents at end of year $ 9,596 $ 26,968 $ 43,585